HARVARD BIOSCIENCE INC
HARVARD BIOSCIENCE INC
Share · US4169061052 · HBIO · 578107 (XNMS)
Overview Financial Indicators
0,42 USD
0,31 % 0,001 USD
NASDAQ/NMS (GLOBAL MARKET) (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 19:11

Current Prices from HARVARD BIOSCIENCE INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
HBIO
USD
06.06.2025 19:11
0,42 USD
0,40 USD
+4,07 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,31 % -7,84 % 26,30 % -48,15 % -80,55 % -86,44 % -85,39 %

Company Profile for HARVARD BIOSCIENCE INC Share

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.

Company Data

Name HARVARD BIOSCIENCE INC
Company Harvard Bioscience, Inc.
Symbol HBIO
Website https://www.harvardbioscience.com
Primary Exchange XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN 578107
ISIN US4169061052
Asset Class Share
Sector Healthcare
Industry Medical - Instruments & Supplies
CEO Mr. James W. Green
Market Capitalization 17 Mio
Country United States of America
Currency USD
Employees 0,3 T
Address 84 October Hill Road, 01746 Holliston
IPO Date 2001-03-19

Stock Splits

Date Split
04.11.2013 1319:1000

Ticker Symbols

Name Symbol
Frankfurt HBI.F
NASDAQ HBIO

More Shares

Investors who HARVARD BIOSCIENCE INC hold also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
ANSYS INC
ANSYS INC Share
AUTODESK INC
AUTODESK INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
DWS SDG GLOBAL EQUITIES LD
DWS SDG GLOBAL EQUITIES LD Fund
INCYTE CORP
INCYTE CORP Share
INTEL CORP
INTEL CORP Share
JYSKE BANK 24/35 FLR MTN
JYSKE BANK 24/35 FLR MTN Bond
MicroSectors U.S. Big Oil Index -3X Inverse Leveraged ETN
MicroSectors U.S. Big Oil Index -3X Inverse Leveraged ETN ETF
MICROSOFT CORP
MICROSOFT CORP Share
MONDELEZ INTERNATIONAL INC - CLASS A
MONDELEZ INTERNATIONAL INC - CLASS A Share
SAREPTA THERAPEUTICSCS INC
SAREPTA THERAPEUTICSCS INC Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025